Wasatch Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-29,000
Closed -$1.33M 359
2017
Q1
$1.33M Hold
29,000
0.02% 292
2016
Q4
$1.52M Hold
29,000
0.02% 278
2016
Q3
$1.29M Hold
29,000
0.02% 290
2016
Q2
$1.11M Hold
29,000
0.02% 309
2016
Q1
$1.18M Sell
29,000
-4,000
-12% -$165K 0.02% 309
2015
Q4
$1.6M Sell
33,000
-8,000
-20% -$356K 0.02% 298
2015
Q3
$1.64M Sell
41,000
-10,000
-20% -$437K 0.02% 297
2015
Q2
$2.05M Sell
51,000
-3,000
-6% -$104K 0.02% 301
2015
Q1
$1.77M Sell
54,000
-6,000
-10% -$166K 0.02% 302
2014
Q4
$1.54M Buy
+60,000
New +$1.43M 0.02% 329

Other funds holding SYNH

Wasatch Advisors's SYNH Position: Q2 2017 in Review

Wasatch Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 29,000 shares — an estimated $1.33M sold.

Wasatch Advisors first reported a position in SYNH in Q4 2014 and held it in 10 quarters. The position peaked at $2.05M in Q2 2015. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Wasatch Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Wasatch Advisors sold 29,000 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $1.33M.
  • Wasatch Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 10 quarters.
  • Wasatch Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $2.05M in Q2 2015.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Wasatch Advisors's 13F filing for Q2 2017, filed 16 Aug 2017.